Korea should support research-oriented generic makers with incentives

The government needs to improve overall pricing conditions for domestic generic makers with an innovative drug technology, said a local professor on April 19.

In a recent symposium organized by the Korean Society of Pharmaceutical Sciences and Technology, Professor Hwang Sung-joo of Chungnam pharmaceutical college said that the government should step up its efforts to create a business-frien...